TCMVX Performance — Nuveen Mid Cap Value Fund, Class A
Data updated: 2026-09-25
TCMVX returned +19.25% year to date and +25.57% over one year to Jul 2026. Annualised returns are +15.21% over 3 years and +9.63% over 5 years. The fund beat its US Mid-Cap Value category average: $100 invested three years ago grew to $153, against $145 for the category, and to $126 over one year, against $120. Volatility over the past three years was 14.10% a year. In the 12 months to Jul 2026 the fund lost a net $228.2M, and assets reached $1.68B.
TCMVX Growth of $100
What $100 invested in Nuveen Mid Cap Value Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | TCMVX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $126 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $153 | $145 |
| 5 years (Aug 2021 – Jul 2026) | $158 | $156 |
| Since data start (Aug 2019 – Jul 2026) | $197 | $212 |
TCMVX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +19.25% |
| 1 year | +25.57% |
| 3 years (annualised) | +15.21% |
| 5 years (annualised) | +9.63% |
TCMVX Annual Returns
Calendar-year total returns of Nuveen Mid Cap Value Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +19.25% |
| 2025 | +7.94% |
| 2024 | +14.14% |
| 2023 | +11.06% |
| 2022 | −10.58% |
| 2021 | +31.82% |
| 2020 | −4.53% |
| 2019 (Aug–Dec) | +7.42% |
TCMVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.1% | +5.0% | −3.7% | +8.4% | +1.3% | +4.1% | −0.8% | — | — | — | — | — |
| 2025 | +3.2% | −1.3% | −5.3% | −1.9% | +3.6% | +3.8% | +0.8% | +1.8% | +1.7% | −0.5% | +1.9% | +0.3% |
| 2024 | −1.6% | +4.7% | +5.4% | −4.7% | +5.5% | −1.4% | +5.0% | +1.5% | +0.8% | −0.3% | +7.1% | −7.6% |
| 2023 | +7.3% | −3.1% | −4.8% | +0.4% | −4.7% | +8.2% | +4.1% | −2.1% | −4.4% | −4.3% | +9.1% | +6.6% |
| 2022 | −4.6% | −0.2% | +1.1% | −4.6% | +0.9% | −9.4% | +8.5% | −1.9% | −9.1% | +10.9% | +4.6% | −5.1% |
| 2021 | −0.2% | +7.3% | +5.7% | +5.2% | +3.3% | −2.1% | +0.9% | +2.1% | −4.1% | +5.5% | −2.3% | +7.4% |
| 2020 | −3.2% | −11.1% | −23.8% | +11.3% | +4.6% | 0.0% | +3.9% | +1.9% | −2.7% | +1.9% | +12.8% | +5.7% |
| 2019 | — | — | — | — | — | — | — | −4.0% | +4.5% | +0.3% | +3.2% | +3.6% |
TCMVX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.10%
- 3-year Sharpe ratio: 0.76 (vs 4.5% risk-free rate)
- Best month: +9.06% (Nov 2023)
- Worst month: −7.57% (Dec 2024)
TCMVX Fund Flows
Monthly money in and out of Nuveen Mid Cap Value Fund, from SEC Form N-PORT.
- 12-month net flow: −$228.2M
- 12-month gross sales (incl. reinvestments): $171.2M
- Sales ÷ redemptions: 0.43×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $7.9M | $43.4M | −$35.6M |
| Jun 2026 | $6.8M | $21.1M | −$14.3M |
| May 2026 | $6.6M | $19.4M | −$12.9M |
| Apr 2026 | $7.3M | $29.4M | −$22.1M |
| Mar 2026 | $3.3M | $34.2M | −$30.9M |
| Feb 2026 | $1.7M | $26.1M | −$24.3M |
| Jan 2026 | $5.8M | $27.7M | −$21.9M |
| Dec 2025 | $122.2M | $35.1M | $87.1M |
| Nov 2025 | $1.5M | $25.0M | −$23.5M |
| Oct 2025 | $6.2M | $32.6M | −$26.4M |
| Sep 2025 | $1.2M | $73.9M | −$72.7M |
| Aug 2025 | $768K | $31.5M | −$30.7M |
TCMVX Assets Under Management
Net assets of Nuveen Mid Cap Value Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.68B |
| 2026-04-30 | $1.67B |
| 2026-01-31 | $1.60B |
| 2025-10-31 | $1.58B |
| 2025-07-31 | $1.63B |
| 2025-04-30 | $1.63B |
| 2025-01-31 | $1.89B |
| 2024-10-31 | $1.85B |
| 2024-07-31 | $1.80B |
| 2024-04-30 | $1.69B |
| 2024-01-31 | $1.67B |
| 2023-10-31 | $1.52B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.